ATE87318T1 - Ricin-antikoerper-konjugate. - Google Patents

Ricin-antikoerper-konjugate.

Info

Publication number
ATE87318T1
ATE87318T1 AT86906742T AT86906742T ATE87318T1 AT E87318 T1 ATE87318 T1 AT E87318T1 AT 86906742 T AT86906742 T AT 86906742T AT 86906742 T AT86906742 T AT 86906742T AT E87318 T1 ATE87318 T1 AT E87318T1
Authority
AT
Austria
Prior art keywords
ricin
antibody conjugates
derivative
tumour cell
antibody
Prior art date
Application number
AT86906742T
Other languages
English (en)
Inventor
Ian Farquhar Campbell Mckenzie
Geoffrey Allan Pietersz
Jerry Kanellos
Original Assignee
Consolidated Pharmaceuticals L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consolidated Pharmaceuticals L filed Critical Consolidated Pharmaceuticals L
Application granted granted Critical
Publication of ATE87318T1 publication Critical patent/ATE87318T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6821Plant heterodimeric toxins, e.g. abrin or modeccin
    • A61K47/6823Double chain ricin
AT86906742T 1985-11-29 1986-12-01 Ricin-antikoerper-konjugate. ATE87318T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH364785 1985-11-29
EP86906742A EP0248040B1 (de) 1985-11-29 1986-12-01 Ricin-antikörper-konjugate
PCT/AU1986/000370 WO1987003286A1 (en) 1985-11-29 1986-12-01 Ricin-antibody conjugates

Publications (1)

Publication Number Publication Date
ATE87318T1 true ATE87318T1 (de) 1993-04-15

Family

ID=3771392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86906742T ATE87318T1 (de) 1985-11-29 1986-12-01 Ricin-antikoerper-konjugate.

Country Status (6)

Country Link
EP (1) EP0248040B1 (de)
AT (1) ATE87318T1 (de)
AU (1) AU609380B2 (de)
DE (1) DE3688137D1 (de)
NZ (1) NZ218460A (de)
WO (1) WO1987003286A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585940B2 (en) * 1984-09-25 1989-06-29 Xoma Corporation Lectin immunotoxins
US4714759A (en) * 1985-12-02 1987-12-22 Whitaker Jr Robert B Immunotoxin therapy of allergy
US5395924A (en) * 1986-03-20 1995-03-07 Dana-Farber Cancer Institute, Inc. Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
US4808705A (en) * 1986-12-19 1989-02-28 Cetus Corporation Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor
EP0303681B1 (de) * 1987-02-24 1992-10-14 Xoma Corporation Immunosuppression bei der auf immunotoxin basierten behandlung von menschen
AU626087B2 (en) * 1987-07-17 1992-07-23 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species
ZA89547B (en) * 1988-02-02 1989-10-25 Akzo Nv Immunotoxins from barley toxin
WO1990014844A2 (en) * 1989-06-06 1990-12-13 Neorx Corporation Sugars as cleavable linkers for the delivery and release of agents in native form
US5635384A (en) * 1990-06-11 1997-06-03 Dowelanco Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
US5248606A (en) * 1990-06-11 1993-09-28 Dowelanco Dna encoding inactive precursor and active forms of maize ribosome inactivating protein

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5616418A (en) * 1979-07-20 1981-02-17 Teijin Ltd Antitumor protein complex and its preparation
FR2466252A2 (fr) * 1979-10-03 1981-04-10 Clin Midy Nouveaux produits ayant notamment des proprietes anticancereuses a base de chaine a de la ricine et d'une proteine
EP0044167A3 (de) * 1980-07-14 1982-04-21 The Regents Of The University Of California Durch einen Antikörper gerichtetes zytotoxisches Mittel
FR2504010B1 (fr) * 1981-04-15 1985-10-25 Sanofi Sa Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
FR2566403B1 (fr) * 1984-06-20 1986-11-07 Sanofi Sa Imidazolides, procede d'obtention et application a titre d'intermediaires de synthese de conjugues cytotoxiques
FR2591895B1 (fr) * 1985-12-20 1988-08-26 Sanofi Sa Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques

Also Published As

Publication number Publication date
EP0248040A1 (de) 1987-12-09
AU6628386A (en) 1987-07-01
WO1987003286A1 (en) 1987-06-04
NZ218460A (en) 1989-07-27
EP0248040A4 (de) 1988-01-07
DE3688137D1 (de) 1993-04-29
EP0248040B1 (de) 1993-03-24
AU609380B2 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
DK651088A (da) Konjugater af laegemidler og monoklonale antistoffer
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
ATE247128T1 (de) Aminoderivatisierte nukleoside und oligonukleoside
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
DK69890A (da) Monoklonale antistoffer, der er reaktive med cachetin
DE3854194D1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
ATE63919T1 (de) Platinkoordinationsverbindungen.
NO863974D0 (no) Monoklonale antihuman brystkreftantistoffer.
ATE87318T1 (de) Ricin-antikoerper-konjugate.
EP0679093A1 (de) Methode zum überbringen von agenzien an zielzellen.
CA2150925A1 (en) Improved synthesis of polymer bio-active conjugates
DE3686313D1 (de) Anti-immuntoxine gegen menschlichen eierstockkrebs und verfahren zu deren verwendung.
FI841260A0 (fi) Immunoglobulinkonjugater.
DK382989A (da) Cytotoxiske vinca-konjugater bundet til antistoffer og fremgangsmaade til fremstilling deraf
NO995978D0 (no) Reseptorbindende konjugater
ATE41414T1 (de) Acetaminophenanaloge, 1-antigene und -antikoerper.
DK0525119T3 (da) Antistofkonjugater til behandling af neoplastisk sygdom
ATE141926T1 (de) Neue cobalamin-säurehydrazide und davon abgeleitete cobalamin-konjugate
ES2001013A6 (es) Un metodo para la preparacion de anticuerpos especificos de histamina
DE3888924D1 (de) Monoklonale Antikörper gegen Anthracycline.
IT1233005B (it) Anticorpo umano monoclonale, composizione terapeutica che lo contiene linea cellulare capace di produrre l'anticorpo, procedimento per la sua produzione
FR2603927A1 (fr) Elements prefabrique en forme de voute pour la construction de batiments divers et batiments obtenus
ES1004429U (es) Caja expositor perfeccionada
ES203853U (es) Pilar universal para vallas y similares.
ES279153U (es) Arqueta para conducciones electricas o de saneamiento indistintamente, para armar en obra, perfeccionada

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties